AKT1 and cancer: Taken together, SIJ1795 and SIJ1772 block mtRAS downstream signaling (MAPK and PI3K/AKT pathways) in not only Ba/F3 cells transformed with mtRAS (NRAS-G12D and NRAS-G12V), but also cancer cells expressing mtRAS in a concentration dependent fashion.